New-onset seizure during and after brain tumor excision: a risk assessment analysis
- 1 June 2018
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 128 (6) , 1713-1718
Abstract
OBJECTIVE: Prophylactic use of antiepileptic drugs (AEDs) in seizure-naïve brain tumor patients remains a topic of debate. This study aimed to characterize a subset of patients at highest risk for new-onset perioperative seizures (i.e., intraoperative and postoperative seizures occurring within 30 days of surgery) who may benefit from prophylactic AEDs.METHODS: The authors conducted a retrospective case-control study of all adults who had undergone tumor resection or biopsy at the authors’ institution between January 1, 2004, and June 31, 2015. All patients with a history of preoperative seizures, posterior fossa tumors, pituitary tumors, and parasellar tumors were excluded. A control group was matched to the seizure patients according to age (± 0 years). Demographic data, clinical status, operative data, and postoperative course data were collected and analyzed.RESULTS: Among 1693 patients who underwent tumor resection or biopsy, 549 (32.4%) had never had a preoperative seizure. Of these 549 patients, 25 (4.6%) suffered a perioperative seizure (Group 1). A total of 524 patients (95.4%) who remained seizure free were matched to Group 1 according to age (± 0 years), resulting in 132 control patients (Group 2), at an approximate ratio of 1:5. There were no differences between the patient groups in terms of age, sex, race, relationship status, and neurological deficits on presentation. Histological subtype (infiltrating glioma vs meningioma vs other, p = 0.041), intradural tumor location (p < 0.001), intraoperative cortical stimulation (p = 0.004), and extent of resection (less than gross total, p = 0.002) were associated with the occurrence of perioperative seizures.CONCLUSIONS: While most seizure-naïve brain tumor patients do not benefit from perioperative seizure prophylaxis, such treatment should be considered in high-risk patients with supratentorial intradural tumors, in patients undergoing intraoperative cortical stimulation, and in patients in whom subtotal resection is likely.Keywords
This publication has 38 references indexed in Scilit:
- Efficacy of postoperative seizure prophylaxis in intra-axial brain tumor resectionsJournal of Neuro-Oncology, 2014
- Extent of Surgical Resection Predicts Seizure Freedom in Low-Grade Temporal Lobe Brain TumorsNeurosurgery, 2012
- Factors associated with seizure freedom in the surgical resection of glioneuronal tumorsEpilepsia, 2011
- Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomasJournal of Neurosurgery, 2009
- Seizure characteristics and control following resection in 332 patients with low-grade gliomasJournal of Neurosurgery, 2008
- A Retrospective Study of the Clinical Outcomes and Significant Variables in the Surgical Treatment of Temporal Lobe Tumor Associated with Intractable SeizuresStereotactic and Functional Neurosurgery, 2004
- A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumorsNeurology, 1996
- Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumoursActa Neurochirurgica, 1990
- Brain Mapping Techniques to Maximize Resection, Safety, and Seizure Control in Children with Brain TumorsNeurosurgery, 1989
- Postoperative Prophylactic Anticonvulsant Therapy in Cerebral GliomasNeurosurgery, 1985